CPH — Cipher Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$339.41m
- CA$327.17m
- $50.45m
Brief: Cipher Pharma Reports Q4 And Full Year 2021 Financial Results
Brief: Cipher Pharmaceuticals Announces Extension Of Distribution And Supply Agreement With Sun Pharmaceutical Industries Inc.
Brief: Cipher Announces Third Quarter And Year-To-Date 2021 Financial Results
Brief: Cipher Pharmaceuticals Reports First Quarter 2021 Financial Results
Brief: Cipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant To Its Normal Course Issuer Bid
Brief: Cipher Pharmaceuticals Reports Q4 Revenue Of $6.1 Mln
Promotion Agreement With Verity Pharmaceuticals Inc.
Brief: Cipher Pharmaceuticals Receives Arbitration Award On Trulance®
Brief: Cipher Pharmaceuticals Reports Third Quarter 2020 Financial Results
Brief: Cipher Pharmaceuticals Announces Normal Course Issuer Bid
Brief: Cipher Pharmaceuticals Reports Q2 Revenue Of $4.7 Mln
Brief: Cipher Pharmaceuticals Appoints New Chief Financial Officer
Brief: Cipher Pharmaceuticals Reports Q4 Total Revenue Of $5.9 Mln
Brief: Cipher Pharmaceuticals Receives Termination Notice From Bausch
Brief: Cipher Pharmaceuticals Inc - QTRLY Total Revenue Increased 20% To $5.8 Million
Brief: Cipher Pharmaceuticals Receives Health Canada Approval For Trulance (Plecanatide)
Brief: Cipher Pharmaceuticals Inc - QTRLY Total Revenue Decreased To $5.6 Million From $7.0 Million.
Brief: Cipher Pharmaceuticals Expects Q2 2019 Earnings Per Share In Range Of $0.04 To $0.05
Brief: Cipher Pharmaceuticals Reports Qtrly Income From Continuing Operations At $0.03 Per Share